CV Sciences (CVSI) Cash from Investing Activities Growth (3y) (2016 - 2023)
CV Sciences (CVSI) Cash from Investing Activities Growth (3y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 15.98% |
| Mar 31, 2021 | 44.88% |
| Dec 31, 2020 | 49.09% |
| Jun 30, 2020 | -59.48% |
| Dec 31, 2019 | -31.67% |
| Sep 30, 2019 | -184.68% |
| Dec 31, 2018 | -58.44% |
| Sep 30, 2018 | 59.44% |
| Jun 30, 2018 | -46.01% |
| Mar 31, 2018 | -694.13% |
| Dec 31, 2017 | -17.54% |
| Jun 30, 2017 | 63.63% |
| Dec 31, 2016 | 107.52% |
| Sep 30, 2016 | 68.18% |